Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Initiation Research Published by Pello Capital

19 Sep 2019 07:00

RNS Number : 8814M
Adamas Finance Asia Limited
19 September 2019
 

RNS REACH

19 September 2019

ADAMAS FINANCE ASIA LIMITED

(the "Company" or "ADAM")

Initiation Research published by Pello Capital

Adamas Finance Asia Limited (AIM: ADAM), the London quoted pan-Asian diversified investment vehicle, is pleased to announce that Pello Capital Limited, the Company's Joint Corporate Broker, has this morning initiated research on ADAM (the "Note").

 

The Note provides a comprehensive introduction to the Company, its focus on investing in pan-Asian small and medium-sized enterprises, its portfolio investments, the Company's commitment to its strategy of providing investors with capital growth and dividend income and the potential opportunities present in ADAM's investable universe.

 

The Note is available to download by visiting the following link:

http://adamasfinance.com/assets/research/pello-capital-initiation-note.pdf

 

For further information, please visit the Company's website at http://adamasfinance.com and follow the Company on Twitter (@AdamasFinance).

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Adamas Finance Asia Limited

+44 (0) 1825 830587

John Croft

 

WH Ireland Limited - Nominated Adviser

 

+44 (0) 20 7220 1666

James Joyce

James Sinclair Ford

VSA Capital Limited - Joint Corporate Broker 

+44 (0) 20 3005 5000

Andrew Monk

Andrew Raca

Pello Capital Limited - Joint Corporate Broker

+44 (0) 20 3700 2500

Tim Sohal

Maitland/AMO - Communications Advisor

+44 (0) 20 7379 5151

James Benjamin

Peter Hamid

 

About Adamas Finance Asia

ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It is committed to providing for investors attractive uncorrelated returns through a combination of capital growth and dividend income well diversified by national geographies and asset classes from the Asian Small and Medium Enterprise (SME) sector.

 

The Company's investment manager, Harmony Capital, which has a dedicated team with established expertise and broad networks across Asia, is focussed on the strategy of creating income and capital growth for shareholders. Harmony Capital is sourcing predominately private opportunities and continues to create a strong pipeline of income generating assets from potential investments in growth sectors across Asia including healthcare, fintech, hospitality, IT and property.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABVLLFKKFEBBK
Date   Source Headline
26th Apr 20117:00 amRNSRepurchase of Fortel shares
12th Apr 20112:04 pmRNSResult of Meeting
23rd Mar 20116:21 pmRNSPosting of Circular
18th Mar 20113:30 pmRNSStrategic Investment
7th Mar 20114:45 pmRNSDirector/PDMR Shareholding
28th Feb 20116:27 pmRNSHolding(s) in Company
18th Feb 20112:31 pmRNSChange of Auditor
18th Feb 20112:04 pmRNSDirector/PDMR Shareholding
29th Dec 201012:46 pmRNSHolding(s) in Company
2nd Dec 20109:35 amRNSHolding(s) in Company
16th Nov 20104:00 pmRNSTR-1: Notification of Major Interest in Shares
1st Nov 20109:40 amRNSStrategic investment in online education
23rd Sep 20107:00 amRNSInterim Results
29th Jul 201011:45 amRNSResult of AGM
8th Jul 20103:23 pmRNSAppointment of Joint Broker
7th Jul 201012:41 pmRNSNotice of AGM
28th Jun 20102:10 pmRNSFinal Results
3rd Jun 20101:49 pmRNSResult of General Meeting
18th May 201010:00 amRNSBonus Issue
8th Mar 20107:00 amRNSFortel Value Up 26% to US$23.9M

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.